-
Start Preamble
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 20, 2020. Such persons may also file a written request for a hearing on the application on or before May 20, 2020.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on March 4, 2020, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, applied to be registered as an importer of the following basic class(es) of controlled substances:
Controlled substance Drug code Schedule Methamphetamine 1105 II Cathinone 1235 I Phenmetrazine 1631 II Methylphenidate 1724 II Amobarbital 2125 II Pentobarbital 2270 II Secobarbital 2315 II Glutethimide 2550 II Methaqualone 2565 I Lysergic acid diethylamide 7315 I 4-Methyl-2,5-dimethoxyamphetamine 7395 I 3,4-Methylenedioxyamphetamine 7400 I 4-Methoxyamphetamine 7411 I Phencyclidine 7471 II ANPP (4-Anilino-N-phenethyl-4-piperidine) 8333 II Phenylacetone 8501 II Alphaprodine 9010 II Anileridine 9020 II Cocaine 9041 II Codeine-N-oxide 9053 I Start Printed Page 21888 Dihydrocodeine 9120 II Difenoxin 9168 I Diphenoxylate 9170 II Heroin 9200 I Levomethorphan 9210 II Levorphanol 9220 II Meperidine 9230 II Dextropropoxyphene, bulk (non-dosage forms) 9273 II Morphine-N-oxide 9307 I Thebaine 9333 II Norlevorphanol 9634 I Oxymorphone 9652 II Noroxymorphone 9668 II Alfentanil 9737 II Sufentanil 9740 II The company plans to import the bulk control substances for distribution of analytical reference standards to its customers for analytical testing of raw materials.
Start SignatureWilliam T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08269 Filed 4-17-20; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 04/20/2020
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2020-08269
- Dates:
- Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 20, 2020. Such persons may also file a written request for a hearing on the application on or before May 20, 2020.
- Pages:
- 21887-21888 (2 pages)
- Docket Numbers:
- Docket No. DEA-617
- PDF File:
- 2020-08269.pdf